ACS Signs $8.7 Million Contract With State of Pennsylvania

DALLAS, Jan. 29 /PRNewswire-FirstCall/ -- Affiliated Computer Services, Inc. (NYSE: ACS) , a premier provider of business process outsourcing and information technology solutions, announced today that it has signed a five-year, $8.7 million contract with the Pennsylvania Department of Public Welfare (DPW) to provide a three-component Medical Management Review System (MMRS) to manage its care management, prior authorization, and case management functions.

The ACS SmartPA Tool provides the Commonwealth with the innovative platform to launch this first-of-a-kind MMRS solution. SmartPA has an established and proven track record in ten other complex state Medicaid programs.

SmartPA is driven by flexible, table-driven criteria that the Department will use for specific prior authorization, case management, and review parameters authorized by the Commonwealth; criteria that can be easily revised over time to meet needs as they evolve. It will generate immediate cost savings and quality improvement, provide immediate feedback to providers on specific claim and clinical issues that result in a recommendation for approval or denial, and maximize efficiency and access to data for DPW users. Additionally, it will provide web interface for DPW users to access patient-specific information in order to quickly and accurately process provider requests. The result will be a new level of integration and coordination across all elements of the DPW care management continuum.

ACS is partnering with CaseNET to deliver its best-in-class case management solutions to DPW.

"This Medical Management Review System is a first-of-its-kind system in the market that will allow government and commercial payors to coordinate and integrate across its enterprise all phases of a comprehensive care management program; case management, prior authorization, concurrent review, and issues and call tracking," said Christopher Deelsnyder, Senior Vice President, ACS Government Healthcare Solutions.

ACS is a national leader in state healthcare program administration, offering a full spectrum of systems and complementary services through an integrated solution. From care management solutions and child health programs to pharmacy benefits management and traditional Medicaid fiscal agent services, ACS has a proven track record and extensive program management expertise. ACS is also a pioneer in fraud and abuse protection and other cost containment methodologies, and is known for its collaborative approach to client relationships that produce results over the long-term. ACS supports over 20 million program recipients and processes nearly 475 million Medicaid healthcare claims annually, representing more than $47 billion in provider payments. As the nation's largest government program pharmacy benefits administrator, ACS serves 30 programs in 25 states and the District of Columbia with drug expenditures totaling over $13 billion.

ACS, a FORTUNE 500 company with 58,000 people supporting client operations reaching 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The Company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS." ACS makes technology work. Visit ACS on the Internet at http://www.acs-inc.com/.

The statements in this news release that do not directly relate to historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to numerous risks and uncertainties, many of which are outside the Company's control. As such, no assurance can be given that the actual events and results will not be materially different than the anticipated results described in the forward-looking statements. Factors could cause actual results to differ materially from such forward-looking statements. For a description of these factors, see the Company's prior filings with the Securities and Exchange Commission, including our most recent filing. ACS disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future event, or otherwise.